VanEck Biotech ETF
BBH
BBH
52 hedge funds and large institutions have $112M invested in VanEck Biotech ETF in 2013 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
2.1% more ownership
Funds ownership: 21.31% → 23.41% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
52
Holding in Top 10
1
Calls
$6.46M
Puts
$2.07M
Top Buyers
| 1 | +$7.06M | |
| 2 | +$3.24M | |
| 3 | +$1.33M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$928K |
| 5 |
NES
New England Securities
New York
|
+$921K |
Top Sellers
| 1 | -$4.43M | |
| 2 | -$1.16M | |
| 3 | -$961K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$425K |
| 5 |
WJA
Williams Jones & Associates
New York
|
-$327K |